Skip to main content

6 Result(s)

within M. E. Keck Remove this filter English Remove this filter Neurosciences Remove this filter

and

  1. No Access

    Article

    TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies

    The lifetime prevalence of panic disorder (PD) is up to 4% worldwide and there is substantial evidence that genetic factors contribute to the development of PD. Single-nucleotide polymorphisms (SNPs) in TMEM13...

    A Erhardt, L Czibere, D Roeske, S Lucae, P G Unschuld, S Ripke… in Molecular Psychiatry (2011)

  2. Article

    Open Access

    The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disorders

    Recent evidence suggests that the GABA transporter 1 (GAT-1; SLC6A1) plays a role in the pathophysiology and treatment of anxiety disorders. In order to understand the impact of genetic variation within SLC6A1...

    C. K. Thoeringer, S. Ripke, P. G. Unschuld, S. Lucae… in Journal of Neural Transmission (2009)

    Download PDF (339 KB) View Article

  3. No Access

    Article

    Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks

    A Erhardt, S Lucae, N Kern, P G Unschuld, M Ising, R Lieb, M Uhr… in Molecular Psychiatry (2008)

  4. No Access

    Chapter

    Mutagenesis and Knockout Models: Hypothalamic-Pituitary-Adrenocortical System

    Hyperactivity of central neuropeptidergic circuits such as the corticotropin-releasing hormone (CRH) and vasopressin (AVP) neuronal systems is thought to play a causal role in the etiology and symptomatology o...

    M.E. Keck, M.B. Müller in Anxiety and Anxiolytic Drugs (2005)

  5. No Access

    Chapter

    Challenge Studies in Anxiety Disorders

    In psychiatry, the use of pharmacological challenges in panic disorder is unique in that the clinical phenomenon of central interest (i.e., the panic attack) can be provoked readily and assessed in the clinica...

    M.E. Keck, A. Ströhle in Anxiety and Anxiolytic Drugs (2005)

  6. Article

    Repetitive Transcranial Magnetic Stimulation Increases the Release of Dopamine in the Nucleus Accumbens Shell of Morphine-Sensitized Rats During Abstinence

    Recent studies in rodents have shown that withdrawal from chronic drug abuse is associated with a significant decrease in dopamine (DA) release in mesolimbic structures, especially in the shell region of the n...

    A Erhardt, I Sillaber, T Welt, M B Müller, N Singewald, M E Keck in Neuropsychopharmacology (2004)

    Download PDF (240 KB) View Article